NCT04720157 2026-03-11
PSMAddition
Novartis
Phase 3 Active not recruiting
Clinical Trials
4 trialsNCT04689828 2026-02-20
PSMAfore
Novartis
Phase 3 Active not recruiting
NCT07200830 2025-10-01
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Alliance for Clinical Trials in Oncology
Phase 3 Not yet recruiting
NCT03511664 2025-01-13
VISION
Endocyte
Phase 3 Completed